Four phase II trials have beenconducted to evaluate the efficacy and tolerability of single-agent docetaxel
James R. Rigas, MD
Advertisement
Articles by James R. Rigas, MD
Advertisement
Latest Updated Articles
- Single-Agent Docetaxel in Previously Untreated Non-Small-Cell Lung Cancer
Published: July 1st 1997 | Updated:
Advertisement
Advertisement
Trending on CancerNetwork
1
What Were the Key Presentations at ESMO 2025? Oncology Experts Discuss
2
Porustobart/Tislelizumab Elicits Responses in MSS Metastatic Colorectal Cancer
3
Classifying High-Risk Patients With NDMM
4
Unraveling the Complexities of Proximal-Type Epithelioid Sarcoma of the Vulva
5
